Maximum Daily Dosage Instructions for Brivaracetam Tablets

Brivaracetam/Brivaracetam is an oral antiepileptic drug with a dose designed to balance efficacy and safety. The initial oral dose for adult patients with epilepsy is generally 50 mg per day, taken in two divided doses, to reduce gastrointestinal irritation and potential central nervous system adverse reactions. The dose may be titrated based on the patient's tolerance and clinical response to the drug. The commonly used clinical maintenance dose range is 25 mg to 100 mg taken orally twice a day to ensure that epileptic seizures can be effectively controlled while minimizing the incidence of adverse events.

The maximum daily dose of brivaracetam is200 mg. Long-term use above this dose is not recommended as high doses may increase the risk of central nervous system side effects, including drowsiness, dizziness, decreased concentration, and mood swings. Dosage adjustment should strictly follow the doctor's guidance, especially in patients with abnormal liver function or elderly patients, the dose should be appropriately reduced to avoid drug accumulation.

You should pay attention to regularity when taking the medicine. The half-life of Brivaracetam is about 7 to 8 hours. Taking it twice in the morning and evening can maintain stable blood concentration, thereby reducing the risk of attack. If a dose is missed, the dose should be taken as soon as possible. However, if the next dose is too close, the dose should be skipped to prevent side effects caused by a short-term increase in blood concentration.

Brivaracetam may also be used in combination with other anti-epileptic drugs. In combination therapy, attention should be paid to the impact of drug interactions on dose adjustment. For example, coadministration with strong CYP2C19 inducers or inhibitors may alter the rate of metabolism of brivaracetam, requiring dose adjustment. In short, following individualized dose management and maximum daily dose specifications is the key to ensuring efficacy and safety.

Reference materials:https://www.briviact.com/